Lu Fu
Impact in
- Virology top 10%
- HIV Research and Treatment
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Natural product bioactivities and synthesis 8
-
- Phytochemistry and Biological Activities 8
- Co-authors
- Megan S. Lord (11 shared papers)Ye Bi (1 shared paper)Lesheng Teng (1 shared paper)John M. Whitelock (6 shared papers)Erik De Clercq (2 shared papers)Christophe Pannecouque (2 shared papers)Wen‐Ming Chen (2 shared papers)Peng Zhan (2 shared papers)
- Journals
- Advanced Healthcare Materials (2 papers)Protein Expression and Purification (2 papers)European Journal of Medicinal Chemistry (2 papers)RSC Advances (2 papers)Journal of Asian Natural Products Research (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Lu Fu
39 papers receiving 681 citations
Peers
Comparison fields: 5 of 95
- Virology 50
- Biomaterials 104
- Complementary and alternative medicine 50
- Infectious Diseases 85
- Pharmacology 33
Countries citing papers authored by Lu Fu
This map shows the geographic impact of Lu Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Fu more than expected).
Fields of papers citing papers by Lu Fu
This network shows the impact of papers produced by Lu Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Fu. The network helps show where Lu Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 108 | |
| 2 | 2015 | 84 | |
| 3 | 2023 | 73 | |
| 4 | 2023 | 69 | |
| 5 | 2015 | 43 | |
| 6 | 2022 | 31 | |
| 7 | 2022 | 29 | |
| 8 | 2022 | 23 | |
| 9 | 2023 | 22 | |
| 10 | 2022 | 18 | |
| 11 | 2014 | 18 | |
| 12 | 2018 | 18 | |
| 13 | 2023 | 15 | |
| 14 | 2023 | 13 | |
| 15 | 2024 | 12 | |
| 16 | 2022 | 10 | |
| 17 | 2015 | 10 | |
| 18 | 2020 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2019 | 7 |
About Lu Fu
Lu Fu is a scholar working on Molecular Biology, Plant Science, Infectious Diseases, Biomaterials and Computational Theory and Mathematics, having authored 44 papers that have together received 692 indexed citations. Recurring topics across this work include Phytochemistry and Biological Activities (8 papers), Natural product bioactivities and synthesis (8 papers), Computational Drug Discovery Methods (5 papers), HIV Research and Treatment (4 papers), Sesquiterpenes and Asteraceae Studies (3 papers), Viral gastroenteritis research and epidemiology (3 papers), Electrospun Nanofibers in Biomedical Applications (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). The work is most often cited by research in Virology (50 citations), Biomaterials (104 citations), Complementary and alternative medicine (50 citations), Infectious Diseases (85 citations) and Pharmacology (33 citations). Lu Fu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Megan S. Lord, Ye Bi, Lesheng Teng, John M. Whitelock, Erik De Clercq, Christophe Pannecouque, Wen‐Ming Chen, Peng Zhan, Cuicui Li and Xinyong Liu. Their work appears in journals such as Advanced Healthcare Materials, Protein Expression and Purification, European Journal of Medicinal Chemistry, RSC Advances and Journal of Asian Natural Products Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.